Onoe Tamehito, Yamada Kazunori, Mizushima Ichiro, Ito Kiyoaki, Kawakami Takahiro, Daimon Shoichiro, Muramoto Hiroaki, Konoshita Tadashi, Yamagishi Masakazu, Kawano Mitsuhiro
Division of Rheumatology, Department of Internal Medicine , Kanazawa University Graduate School of Medicine , Kanazawa , Japan.
Department of Nephrology , Daimon Clinic for Internal Medicine, Nephrology and Dialysis , Nonoichi , Japan.
Clin Kidney J. 2016 Feb;9(1):69-75. doi: 10.1093/ckj/sfv110. Epub 2015 Dec 17.
Uromodulin kidney disease (UKD) is an inherited kidney disease caused by a uromodulin (UMOD) gene mutation. The UMOD gene encodes the Tamm-Horsfall protein (THP), which is the most abundant protein in healthy human urine. Because of its rarity, the incidence of UKD has not been fully elucidated. The purpose of the present study is to clarify the frequency of UKD among patients who underwent renal biopsy.
Immunostaining for THP was performed for patients <50 years of age with renal insufficiency and hyperuricemia without overt urinalysis abnormality from renal biopsy databases. Serum and urinary THP concentrations were evaluated in available individuals.
Fifteen patients were selected for immunostaining from a total of 3787 patients. In three independent patients, abnormal THP accumulation in renal tubular cells was observed. A novel missense A247P UMOD mutation was detected in two of the three patients, including one having a typical family history of familial juvenile hyperuricemic nephropathy. Serum and urinary THP concentrations of all available patients with UMOD A247P mutation were significantly lower than those of controls.
In the present study, UKD was detected in <1 in 1000 subjects who underwent renal biopsies. However, in subjects meeting all of the above criteria, abnormal THP accumulation was detected in 20% (3/15), suggesting that renal biopsy with immunostaining for THP is a good tool for diagnosing UKD. Also, low serum THP concentration detected in the present subjects might be a good diagnostic marker or important in understanding the pathogenesis of UKD.
尿调节素肾病(UKD)是一种由尿调节素(UMOD)基因突变引起的遗传性肾病。UMOD基因编码Tamm-Horsfall蛋白(THP),它是健康人尿液中含量最丰富的蛋白质。由于其罕见性,UKD的发病率尚未完全阐明。本研究的目的是明确接受肾活检的患者中UKD的发生率。
对来自肾活检数据库的年龄小于50岁、患有肾功能不全和高尿酸血症且尿常规无明显异常的患者进行THP免疫染色。对可获取样本的个体评估血清和尿THP浓度。
从总共3787例患者中选取15例进行免疫染色。在3例独立患者中,观察到肾小管细胞中THP异常蓄积。在其中2例患者中检测到一种新的错义A247P UMOD突变,其中1例具有家族性青少年高尿酸血症肾病的典型家族史。所有可获取样本的携带UMOD A247P突变患者的血清和尿THP浓度均显著低于对照组。
在本研究中,在接受肾活检的1000例受试者中UKD的检出率低于1/1000。然而,在符合上述所有标准的受试者中,20%(3/15)检测到THP异常蓄积,提示对THP进行免疫染色的肾活检是诊断UKD的良好工具。此外,本研究中检测到的低血清THP浓度可能是一个良好的诊断标志物或对理解UKD的发病机制具有重要意义。